InvestorsHub Logo
Followers 21
Posts 1400
Boards Moderated 0
Alias Born 03/03/2021

Re: norisknorewards post# 542286

Friday, 12/02/2022 10:07:25 AM

Friday, December 02, 2022 10:07:25 AM

Post# of 694339
norisk... I have been not drinking the MRK/NWBO patent protection Kool-aid because of this 2021 article, now further backed up by your current find. Even if they loose partections for I.V., their shot version of Keytruda will be the more patient friendly and cheaper option. They will get the I.P./Patent protection they need after 2028. IMHO.

https://www.fiercepharma.com/drug-delivery/merck-posts-early-clinical-data-subcutaneous-keytruda-setting-stage-for-further
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-could-keep-its-patent-edge-by-shifting-keytruda-cancer-drug-simple-shot-2022-12-02/

ASM= Actively Supporting Management

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News